PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients Read more
AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform Read more
EdiGene and Immunochina Announce R&D Collaboration to Develop Allogeneic CAR-T Therapy for Cancer Read more
Thermo Fisher Scientific Extends Collaboration with Biognosys to Enhance Protein Quantitation Mass Spectrometry Workflows Read more